Tags » Patent

Bits and Pieces: Value of Weak Patents, Assessing CETA and the Contribution of Academic Knowledge to Industry

Here are three publications that caught our eye:

  1. The Value of a ‘Weak’ Patent (see here)

A Monte Carlo simulation is used to value weak patents in this interesting study. 177 more words

Patent

France uses tax to put pressure on hepatitis C drug prices

Source: Reuters

* State spending on hep C drugs to be capped each year

* Tax to hit firms whose drugs throw spending off course… 489 more words

Access To Medicines

Dear Prime Minister Modi: Stand firm for affordable medicines

Source: South Asia Foreign Policy

As Prime Minister Narendra Modi makes his first official visit to the United States, one issue at the top of the trade agenda is the strikingly different approaches of the Indian and U.S. 956 more words

Access To Medicines

Modi Visit Unlikely To Yield Major Outcomes On Trade, Economic Issues

Source: World Trade Online

September 29,2014

Senior administration officials have made clear that Indian Prime Minister Narendra Modi’s Sept. 29-30 trip to Washington is not expected to yield major outcomes on trade issues when they omitted them from the list of areas where they expect to announce commitments. 1,129 more words

IP Rights

BMS tries to block access to generic HIV drug in Venezuela

BMS tries to block access to generic HIV drug in Venezuela,

Tries to obtain injunction in India but fails before the Trial Court

The Pan American Health Organisation (PAHO) had issued a tender earlier in 2012 and again in 2013 for supply of Atazanavir to the Ministry of Health in Venezuela. 882 more words

Patent

MSF urges Prime Minister Modi to resist US political pressure to restrict global access to medicines

Source: MSF Access

September 26, 2014, Delhi/New York – As Indian Prime Minister Narendra Modi makes his first official visit to the United States,Médecins Sans Frontières/Doctors Without Borders (MSF) is urging the Indian government to resist U.S. 434 more words

Access To Medicines

Patent Bits and Pieces: the Future of the Federal Circuit, When Can You Amend in UK Litigation, Non-Patent Incentives, Patent Pools and Personalised Medicine

Here’s a collection of interesting items we recently came across:

1. ‘Coming of Age for the Federal Circuit’ is a paper by Professor Feldman about what the Supreme Court is trying to tell the Federal Circuit through recent decisions. 185 more words

Patent